Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that members of its executive team will present and host 1x1 meetings at the Stifel ...

Themed "Driving Change Through Innovation and Collaboration," the Summit delivered two days of real-world experiences, bringing state-of-the-science practice strategies to oncology nurses through ...

Since his diagnosis, Dave Coulier says he has become aware of the “ingredients, chemicals and materials that are in our foods ...

During a live event, Catherine J. Lee, MD, MS, discussed the mechanism of action of approved therapies for chronic ...

Dave Coulier, who shared he had been diagnosed with Non-Hodgkin lymphoma last year, had some exciting news to share on Monday ...

Actor and comedian Dave Coulier, best known for his role as Joey Gladstone in the hit sitcom “Full House,” is know cancer ...

Bispecific antibodies have become component in the arsenal of treatments for hematologic malignancies; management of their side effects is crucial to their success.

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...

Despite flat revenue growth, ADC Therapeutics SA (ADCT) strengthens its financial position with reduced losses and promising trial data.

"Full House" star Dave Coulier revealed this week that he is cancer-free after undergoing chemotherapy following a diagnosis ...

In a new interview, Dave Coulier revealed he was recently hospitalized for several days after catching a cold. He said his doctors told him if he had come in later, they might not have been able to ...

Lead program investigating MT-601 in patients with refractory lymphomas, including anti-CD19 CAR-T cell therapy, demonstrated safety and efficacy ...